Insights

Innovative Aging Reversal Turn Biotechnologies specializes in cutting-edge rejuvenation therapies targeting multiple aging-related indications, which presents opportunities to collaborate with pharmaceutical and biotech firms focused on anti-aging and regenerative medicine.

Strategic Asset Divestment The recent sale of assets to Klotho Neurosciences and the ongoing partnership with Klotho offer potential avenues to explore licensing, joint development, or technology acquisition opportunities for companies interested in expanding their aging intervention portfolios.

Expanding Therapeutic Pipeline Turn is actively developing eye and ear therapies through licensing agreements, indicating a focus on niche, high-impact medical areas that could open doors for specialized partnerships or funding in ophthalmic and otic disease markets.

Technology Platform Offerings The launch of the eTurna delivery platform and proprietary epigenetic reprogramming technologies suggest opportunities for collaboration with firms seeking innovative delivery solutions or advanced gene editing tools.

Research and Innovation Strength Led by industry veterans and with recent high-profile research hires, Turn’s focus on cutting-edge cell rejuvenation and mRNA medicines provides prospects for strategic alliances, joint research initiatives, or contract research services targeting the aging biotech space.

Turn Biotechnologies Tech Stack

Turn Biotechnologies uses 8 technology products and services including jQuery CDN, Open Graph, Microsoft PowerPoint, and more. Explore Turn Biotechnologies's tech stack below.

  • jQuery CDN
    Content Delivery Network
  • Open Graph
    Content Management System
  • Microsoft PowerPoint
    Editors
  • Microsoft Outlook
    Email
  • Microsoft
    Miscellaneous
  • Microsoft Project
    Project Management
  • HSTS
    Security
  • Google Search Console
    Web Analytics

Media & News

Turn Biotechnologies's Email Address Formats

Turn Biotechnologies uses at least 1 format(s):
Turn Biotechnologies Email FormatsExamplePercentage
First.Last@turn.bioJohn.Doe@turn.bio
98%
First.L@turn.bioJohn.D@turn.bio
2%

Frequently Asked Questions

Where is Turn Biotechnologies's headquarters located?

Minus sign iconPlus sign icon
Turn Biotechnologies's main headquarters is located at 319 North Bernardo Avenue Mountain View, California 94043 United States. The company has employees across 3 continents, including North AmericaAfricaEurope.

What is Turn Biotechnologies's official website and social media links?

Minus sign iconPlus sign icon
Turn Biotechnologies's official website is turn.bio and has social profiles on LinkedInCrunchbase.

What is Turn Biotechnologies's SIC code NAICS code?

Minus sign iconPlus sign icon
Turn Biotechnologies's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Turn Biotechnologies have currently?

Minus sign iconPlus sign icon
As of June 2026, Turn Biotechnologies has approximately 15 employees across 3 continents, including North AmericaAfricaEurope. Key team members include Executive Board Member, Svp Global Corporate & Business Development: M. B.Associate Vice President R&d: N. B. P. E.Senior Director Of Scientific Research: T. M.. Explore Turn Biotechnologies's employee directory with LeadIQ.

What industry does Turn Biotechnologies belong to?

Minus sign iconPlus sign icon
Turn Biotechnologies operates in the Biotechnology Research industry.

What technology does Turn Biotechnologies use?

Minus sign iconPlus sign icon
Turn Biotechnologies's tech stack includes jQuery CDNOpen GraphMicrosoft PowerPointMicrosoft OutlookMicrosoftMicrosoft ProjectHSTSGoogle Search Console.

What is Turn Biotechnologies's email format?

Minus sign iconPlus sign icon
Turn Biotechnologies's email format typically follows the pattern of First.Last@turn.bio. Find more Turn Biotechnologies email formats with LeadIQ.

When was Turn Biotechnologies founded?

Minus sign iconPlus sign icon
Turn Biotechnologies was founded in 2018.

Turn Biotechnologies

Biotechnology ResearchCalifornia, United States11-50 Employees

Aging has been called “the emperor of all maladies.” Turn Bio’s goal is to address multiple aging-related indications using a single powerful reprogramming therapy that turns old cells young again, aiding in the rejuvenation of an aged human body.

In 2013, a paper in Cell (The hallmarks of aging, López-Otin et al.,) proposed nine key “Hallmarks of Aging” that are causes of the general phenotype we refer to as “aging.” Our team recognized that it would be necessary to “turn back the clock” on each of these hallmarks and so set out to develop the technology to do just that. The task was achieved by a using a proprietary cocktail of transiently-administered rejuvenation factors that have now been shown to reverse eight of the nine hallmarks.

Join us as we embark on the task to "turn back time."

Section iconCompany Overview

Headquarters
319 North Bernardo Avenue Mountain View, California 94043 United States
Website
turn.bio
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2018
Employees
11-50

Section iconFunding & Financials

  • $1M$10M

    Turn Biotechnologies's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $1M$10M

    Turn Biotechnologies's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.